Esperanza Villanueva-Siles
Ohad D. Rotenberg
Sophia N. Palmer
<p>Minimally Invasive Gynecologic Surgery</p>
<p>Advanced Gynecologic Ultrasound</p>
<p>Individualized, Patient-Centered Care</p>
<p>Uterine Fibroids, Adenomyosis, Endometriosis, Abnormal Uterine Bleeding, Pelvic Pain, Myofascial Pain, Endometrial polyps, Abnormal PAP Smears, Cervical Dysplasia, Polycystic Ovarian Syndrome (PCOS), Infertiilty, Vulvar disorders.</p>
<p> </p>
<p><span style="text-decoration: underline;"><strong>Publications and Abstracts </strong></span></p>
<p><strong>Palmer S</strong>, Greenburg JA. Transcervical sterilization: A comparison of Essure permanent birth control system and Adiana permanent contraception system. Rev Obstet Gynecol. 2009 Spring;2(2):84-92.</p>
<p><strong>Palmer S</strong>, Chudnoff S, Levie M. Knowledge of Basic Electrosurgical Principles: A Survey of Surgeons Albert Einstein College of Medicine, Resident Research Day June 2008</p>
<p>AAGL 38th Global Congress of Minimally Invasive Gynecology Nov 2009 Levie M, Chudnoff S, <strong>Palmer S</strong>. Hysteroscopic Placement of Essure Device in an Office Setting: A Critical Analysis</p>
<p>AAGL 37th Global Congress of Minimally Invasive Gynecology Nov 2008 Blackwood A, Young M, Schuchter L , Guerry D, Dhulipala R , <strong>Palmer S</strong>, Ganguly A. Multiple Primary Melanoma, Family History, and Germline Mutations in CDKN2A. 1999 ASCO Annual Meeting</p>
Nicole S. Nevadunsky
<p>Comprehensive care of women with uterine, cervical, and vulvar cancers. Interests include minimally invasive and robotic techniques. </p>
<p>Dr. Nicole Nevadunsky conducts translational research that enables her to deliver the highest quality care for her patients. She specializes in the prevention and treatment of gynecologic cancers. Recent clinical studies have evaluated palliative care in improving quality of life in patients with high risk primary or recurrent gynecologic malignancies; and physical activity interventions for endometrial cancer survivors.</p>
Chuanyong Lu
Ken Yu Lin
Radical cancer surgery and minimally invasive surgery using laparoscopy and the da Vinci robotic platform
The long-term objective of Dr. Lin’s research is to develop immunotherapy and biomarker-driven targeted therapy for gynecologic cancers.
<p>Ken Yu Lin, MD, is an Associate Professor, Obstetrics & Gynecology and Women’s Health at Montefiore Einstein. He provides comprehensive, compassionate evidence-based care for women with gynecologic cancers. Dr. Lin performs radical cancer surgery and minimally invasive surgery using laparoscopy and the da Vinci robotic platform.</p><p>After obtaining his Bachelor of Science in chemistry from Stanford University in 1997, Dr. Lin earned his Doctor of Philosophy in biochemistry and cell and molecular biology at Johns Hopkins University in 2006, where he performed research in tumor immunology. He received his Doctor of Medicine at Northwestern University in 2007 before completing an obstetrics & gynecology residency at Yale-New Haven Hospital in 2011. He then completed his gynecologic oncology fellowship at the University of Texas Southwestern Medical Center in 2015.</p><p>The long-term objective of Dr. Lin’s research is to develop immunotherapy and biomarker-driven targeted therapy for gynecologic cancers. Through his collaborations with biomedical scientists and participation in NRG Oncology, Dr. Lin’s research spans several areas. These include developing immunotherapy for ovarian cancer, the biology of uterine serous carcinoma and developing therapy for gynecologic cancers of less common histology, particularly ovarian clear cell carcinoma and carcinosarcoma. His work has been published in numerous peer-reviewed journals, books, chapters, articles and abstracts, including <em>Cancer Research</em>, <em>Cell</em>, and <em>Science Translational Medicine</em>.</p><p>Dr. Lin is board certified in Obstetrics & Gynecology and Gynecologic Oncology and is a member of the Society of Gynecologic Oncology. He participated in the Reproductive Scientist Development Program (RSDP) from 2015 to 2018 and won the Gynecological Oncology Group (GOG) Foundation Early Investigator Award in 2019. He serves on the NRG Oncology Rare Tumor Committee.</p>
Sara S. Isani
<p>Gynecological Oncology</p>
Clinical focus is on pre-cancers and cancers of the reproductive tract. She performs specialized cancer surgery as well as chemotherapy management of these conditions, and also cares for women with hereditary syndromes that increase risk of gynecologic malignancy.
Dr. Isani’s clinical research includes trials to improve cancer survival and quality of life for cancer patients, as well as issues related to access of care.
<p>Sara Isani, MD, is Attending Physician at Montefiore and Associate Professor of Obstetrics and Gynecology & Women’s Health at our Albert Einstein College of Medicine. Her clinical focus is on pre-cancers and cancers of the reproductive tract. She performs specialized cancer surgery as well as chemotherapy management of these conditions, and also cares for women with hereditary syndromes that increase risk of gynecologic malignancy.</p><p>In 2001, Dr. Isani received her Bachelor of Arts in Ecology and Evolutionary Biology from Princeton University. In 2002, she attended New York University School of Medicine, earning her Doctor of Medicine degree in 2006. She started her postgraduate training with an internship and residency in Obstetrics and Gynecology at Yale New Haven Hospital from 2006 to 2010. She then pursued a Gynecologic Oncology fellowship at Albert Einstein College of Medicine, completing the two-year fellowship in 2013.</p><p>Dr. Isani’s clinical research includes trials to improve cancer survival and quality of life for cancer patients, as well as issues related to access of care. Her work has been published in peer-reviewed journals, book chapters and abstracts.</p><p>Dr. Isani is board certified in obstetrics and gynecology and gynecologic oncology. She is a member of the Society of Gynecologic Oncology and the American Congress of Obstetrics and Gynecology.</p>
Tiffany M. Hebert
<p style="margin: 11pt 0in;"> </p>
<p class="MsoNormal"><span class="normaltextrun"><span style="mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; color: #595959; background: white;">Dr. Tiffany M. Hébert, Associate Professor of Pathology, is a graduate of Princeton University (A.B., <em style="mso-bidi-font-style: normal;">summa cum laude</em>) and the Michigan State University College of Human Medicine (M.D.). She completed Anatomic and Clinical Pathology (AP/CP) residency, Cytopathology fellowship and Gynecologic Pathology fellowships, all at Montefiore Medical Center/Albert Einstein College of Medicine. She holds American Board of Pathology certification in Anatomic Pathology, Clinical Pathology and Cytopathology. She has been involved in resident education at Montefiore since her days as Education Chief Resident within the Residency Program, when she created the Resident-Faculty Mentor Program. She served as Associate Program Director for 7 years and is currently the Program Director for the Anatomic and Clinical Pathology Residency Program at Montefiore Health System. Dr. Hébert is also dedicated to medical school education, having previously co-directed the second-year medical school Reproductive Systems course from 2012-2018. She currently contributes to the medical school as a co-chair of the Albert Einstein College of Medicine Admissions Committee, member of the medical school Executive Committee, and representative on the faculty Senate Council. Dr. Hébert was elected by her peers to the Leo M. Davidoff Society of the Albert Einstein College of Medicine which honors excellence in teaching. She is a co-author of the College of American Pathologists' Patient Safety course, "Creating a Culture of Patient Safety" and has contributed nationally to residency education scholarship in presentations at the Association of Pathology Chairs Annual Meeting and the American Board of Pathology’s Annual Summit. </span></span></p>
<p class="MsoNormal"><span class="normaltextrun"><span style="mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; color: #595959; background: white;">Dr. Hebert's primary clinical focus is gynecologic pathology. She is a member of the departmental gynecologic pathology team, reviewing challenging gynecologic pathology cases and participating in the multi-disciplinary gynecologic oncology tumor board. She is a core faculty member for the gyn/breast fellowship at Montefiore. </span></span></p>
<p class="MsoNormal"><span class="normaltextrun"><span style="mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; color: #595959; background: white;">Dr. Hebert's primary areas of research focus are cervical cancer and pathology education. She participates in collaborative research on gynecologic malignancies, both within Einstein and internationally. The main focus of her work is capacity-building mentorship, training, and cervical HPV/HIV related disease research as part of the NCI-funded project, "Developing Rwandan Research Capacity in Cervical Carcinoma and other AIDS malignancies." Dr. Hebert has an ongoing commitment to participation in capacity-building, collaborative research projects in Rwanda and the Democratic Republic of Congo, as a member of the mentorship team for the Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies.</span></span></p>
<p class="MsoNormal"><span class="normaltextrun"><span style="mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; color: #595959; background: white;"> Dr. Hebert's other primary research focus is in pathology education, particularly on curricular development in residency training.</span></span></p>
<p> </p>
<p>Dr. Hebert is a surgical pathologist whose clinical focus is gynecologic pathology, with specific interest in cervical cancer.</p><p> </p>
Dr. Hebert participates in collaborative research on gynecologic malignancies. The main focus of her work is capacity-building mentorship, training, and cervical HPV/HIV-related disease research as part of the NCI-funded project, Developing Rwandan Research Capacity in Cervical Carcinoma and other AIDS malignancies. Dr. Hebert has an ongoing commitment to participation in capacity-building and collaborative research projects in Rwanda and the Democratic Republic of Congo, as a member of the mentorship team for the Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies. Dr. Hebert's other primary research focus is in pathology education, focusing on curriculum development in residency training.
<p><span style="font-family: Arial; font-size: medium;">A significant portion of Dr. Hebert's scientific contributions relate to medical education, particularly in the field of pathology residency education. She has contributed to the national pathology scholarship on curricular innovation.</span></p>
<p><strong>Hébert TM</strong>, Szymanski J, Mantilla J, McLemore L, Walsh R, Vasovic L, Steinberg JJ, Prystowsky MB. Onboarding for Pathology Residency Programs-The Montefiore Experience. Acad Pathol. 2016 Jan-Dec;3:2374289516639979. PubMed PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/28725763/">28725763</a>; PubMed Central PMCID: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497907/">PMC5497907</a>.</…;
<p><strong>Hébert TM</strong>, Maleki S, Vasovic LV, Arnold JL, Steinberg JJ, Prystowsky MB. A team-based approach to autopsy education: integrating anatomic and clinical pathology at the rotation level. Arch Pathol Lab Med. 2014 Mar;138(3):322-7. PubMed PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/24576026/">24576026</a>.</p>
<p>Prystowsky MB, Steinberg J, Cole A, <strong>Hébert TM</strong>. Answering the Call. Adapting Pathology Training to Meet the Needs of 21<sup>st</sup>-Century Medicine. <em>The Pathologist.</em> 2019. https://thepathologist.com/outside-the-lab/answering-the-call. Accessed June 18, 2019.</p>
<p><strong>Hébert TM</strong>, Cole A, Panarelli N, Hu S, Jacob J, Ahlstedt J, Steinberg JJ, Prystowsky MB. Training the Next Generation of Pathologists: A Novel Residency Program Curriculum at Montefiore Medical Center/Albert Einstein College of Medicine. <em>Academic Pathology.</em> 2019; May 30:6:2374289519848099. doi: 10.1177/2374289519848099. Accessed June 18, 2019.</p>
<p>Murenzi G, Dusingize J, Rurangwa T, Sinayobye J, Munyaneza A, Murangwa A, Zawadi T, <strong>Hebert T</strong>, Mugenzi P, Adedimeji A, Mutesa L, Anastos K, Castle P. Protocol for the Study of Cervical Cancer Screening Technologies in HIV-infected Women Living in Rwanda. <em>BMJ Open.</em> 2018; 8 (8):e020432; dio:10.1136/bmjopen-2017-20432. doi: 10.1136/bmjopen-2017-020432.</p>
<p><span style="font-family: Arial;"><span style="font-size: medium;"><span style="text-decoration: underline;">Complete List of Published Work:</span><br /></span></span><a href="https://www.ncbi.nlm.nih.gov/myncbi/1fqekvnKlKEAv/bibliography/47871935… style="font-family: Arial; font-size: medium;">https://www.ncbi.nlm.nih.gov/myncbi/1fqekvnKlKEAv/bibliography/47871935…;
<p>Tiffany Michele Hébert, MD, is Residency Program Director, Anatomic and Clinical Pathology, Anatomic Pathology Site Director and Associate Professor, Pathology at Montefiore Einstein. Dr. Hébert is a surgical pathologist whose clinical focus is gynecologic pathology, with specific interest in cervical cancer.</p><p>After earning her Doctor of Medicine at Michigan State University College of Human Medicine in 2002, Dr. Hébert completed her anatomic and clinical pathology residency at Einstein in 2006. During this time, she was anatomic pathology chief resident for one year followed by pathology education chief resident for another two years. She was elected as a resident member of the Leo M. Davidoff society for Outstanding Achievement in the Teaching of Medical Students in 2006. Dr. Hébert remained at Einstein to complete a one-year cytopathology fellowship in 2007, which preceded a one-year junior attending/gynecologic pathology subspecialty training.</p><p>Dr. Hébert participates in collaborative research on gynecologic malignancies. The main focus of her work is capacity-building mentorship, training, and cervical human papillomavirus/human immunodeficiency virus (HPV)/(HIV) related disease research as part of the National Cancer Institute (NCI)-funded project, Developing Rwandan Research Capacity in Cervical Carcinoma and other AIDS malignancies. Dr. Hebert has an ongoing commitment to participation in capacity-building and collaborative research projects in Rwanda and the Democratic Republic of Congo, as a member of the mentorship team for the Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies. Dr. Hébert’s other primary research focus is in pathology education, focusing on curriculum development in residency training. Her work has been published in numerous original communications, peer-reviewed journals and abstracts. She has given national and international invited presentations.</p><p>Dr. Hébert is board certified in Anatomic and Clinical Pathology and Cytopathology by the American Board of Pathology. She is a fellow of the American Society for Clinical Pathology and the College of American Pathologists. She is also a member of the New York Pathology Society and the International Society of Gynecologic Pathologists. In 2013, Dr. Hébert was Elected Faculty Member of the Leo M. Davidoff Society for Outstanding Achievement in the Teaching of Medical Students at Einstein. In 2016, she was admitted to the inaugural class of the Association of Pathology Chairs Leadership Academy.</p>
Michelle R. Ewart
<p>Anatomic Pathology.</p>
<p>Subspecialty interest: Pediatric and Perinatal Pathology. </p>